Zobrazeno 1 - 10
of 45
pro vyhledávání: '"WILLIAM T. FRIEDEWALD"'
Autor:
Matthew C. Riddle, Hertzel C. Gerstein, Vivian Fonseca, Faramarz Ismail-Beigi, Jeffrey L. Probstfield, William T. Friedewald, J. Thomas Bigger, Saul Genuth, Stephen J. Giddings, John B. Buse, William C. Cushman, Nancy L. Geller, Daniel P. Beavers, Alain G. Bertoni, Richard H. Grimm, Ruth Kirby, Elizabeth R. Seaquist, Timothy E. Craven, Carlos R Lopez Jimenez, Irene Hramiak
Publikováno v:
Diabetes Care
OBJECTIVE In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, ∼4 years of intensive versus standard glycemic control in participants with type 2 diabetes and other cardiovascular risk factors had a neutral effect on the composi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbac2c88c5b378ea64edfb30d0e0ca22
http://europepmc.org/articles/PMC4839177
http://europepmc.org/articles/PMC4839177
Autor:
Michael Rosenbaum, Panos N. Papapanou, Ryan T. Demmer, David R. Jacobs, William T. Friedewald, Moïse Desvarieux, Anthony I. Squillaro
Publikováno v:
Diabetes Care. 35:2235-2242
OBJECTIVE Adverse microbial exposures might contribute to diabetogenesis. We hypothesized that clinical periodontal disease (a manifestation of microbial exposures in dysbiotic biofilms) would be related to insulin resistance among diabetes-free part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f016b7d296de68815b8692a33e731529
https://doi.org/10.2337/dc12-0072
https://doi.org/10.2337/dc12-0072
Autor:
Nancy L. Geller, John S. Witte, William T. Friedewald, Steven I. Goodman, Ralph B. D'Agostino, David L. DeMets
Publikováno v:
Statistics in medicine, vol 31, iss 25
A panel discussion on the future of clinical trials addressed several issues raised in the course of the first day of the Workshop. The chair posed questions in six areas which the panel and audience addressed. This paper summarizes the panel discuss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932723ce4b79255c5a683b6759747dc9
https://doi.org/10.1002/sim.5484
https://doi.org/10.1002/sim.5484
Autor:
William C, Cushman, Gregory W, Evans, Robert P, Byington, David C, Goff, Richard H, Grimm, Jeffrey A, Cutler, Denise G, Simons-Morton, Jan N, Basile, Marshall A, Corson, Jeffrey L, Probstfield, Lois, Katz, Kevin A, Peterson, William T, Friedewald, John B, Buse, J Thomas, Bigger, Hertzel C, Gerstein, LeRoy, Walters
Publikováno v:
New England Journal of Medicine. 362:1575-1585
There is no evidence from randomized trials to support a strategy of lowering systolic blood pressure below 135 to 140 mm Hg in persons with type 2 diabetes mellitus. We investigated whether therapy targeting normal systolic pressure (i.e.,120 mm Hg)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b869046498884e4ba913dfc2bff2bbc
https://doi.org/10.1056/nejmoa1001286
https://doi.org/10.1056/nejmoa1001286
Autor:
Randall Merchant, Ramon Diaz-Arrastia, Shelly D. Timmons, Beth M. Ansel, Joseph H. Ricker, Thomas A. Novack, Shing M. Lee, Howard M. Eisenberg, Bruce Levin, Ross Zafonte, William T. Friedewald, Jack Jallo, Nancy R. Temkin
Publikováno v:
Journal of Neurotrauma. 26:2207-2216
Traumatic brain injury (TBI) is a major cause of death and disability. In the United States alone approximately 1.4 million sustain a TBI each year, of which 50,000 people die, and over 200,000 are hospitalized. Despite numerous prior clinical trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b154c47d9e2387194fb9512cd5fb94e3
https://doi.org/10.1089/neu.2009.1015
https://doi.org/10.1089/neu.2009.1015
Autor:
John B, Buse, J Thomas, Bigger, Robert P, Byington, Lawton S, Cooper, William C, Cushman, William T, Friedewald, Saul, Genuth, Hertzel C, Gerstein, Henry N, Ginsberg, David C, Goff, Richard H, Grimm, Karen L, Margolis, Jeffrey L, Probstfield, Denise G, Simons-Morton, Mark D, Sullivan
Publikováno v:
The American Journal of Cardiology. 99:S21-S33
Most patients with type 2 diabetes mellitus develop cardiovascular disease (CVD), with substantial loss of life expectancy. Nonfatal CVD contributes greatly to excess healthcare costs and decreased quality of life in patients with diabetes. The curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcbac0678abaa8896765c095a286ac6d
https://doi.org/10.1016/j.amjcard.2007.03.003
https://doi.org/10.1016/j.amjcard.2007.03.003
Autor:
Carlos López, David C. Goff, Lawrence A. Leiter, Marshall B. Elam, Marshall A. Corson, Robert P. Byington, Mary Ellen Sweeney, Hertzel C. Gerstein, Laura C. Lovato, Jerome L. Fleg, John B. Buse, Patrick J. O'Connor, Richard H. Grimm, Daniel J. Weiss, Yves Rosenberg, Jeffrey L. Probstfield, William T. Friedewald, Joseph Largay, Faramarz Ismail-Beigi, Henry N. Ginsberg
Publikováno v:
JAMA Cardiology. 2:370
Importance Patients with type 2 diabetes are at high risk of cardiovascular disease (CVD) in part owing to hypertriglyceridemia and low high-density lipoprotein cholesterol. It is unknown whether adding triglyceride-lowering treatment to statin reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5452bc22a8d757d1c1ba6eedd34586
https://doi.org/10.1001/jamacardio.2016.4828
https://doi.org/10.1001/jamacardio.2016.4828
Publikováno v:
The American Journal of Cardiology. 99:S1-S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38d95c9666e2623448c737800629e452
https://doi.org/10.1016/j.amjcard.2007.03.001
https://doi.org/10.1016/j.amjcard.2007.03.001
Autor:
Ramon Diaz-Arrastia, Sureyya Dikmen, Emilia Bagiella, Nancy R. Temkin, Dale C. Hesdorffer, Howard M. Eisenberg, Jack Jallo, Randall Merchant, Ross Zafonte, Tessa Hart, Sherry M. Melton, Joseph H. Ricker, William T. Friedewald, Beth M. Ansel, Thomas A. Novack, Shelly D. Timmons
Publikováno v:
JAMA. 308(19)
Traumatic brain injury (TBI) is a serious public health problem in the United States, yet no treatment is currently available to improve outcome after TBI. Approved for use in TBI in 59 countries, citicoline is an endogenous substance offering potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaea05804066faadd1c2a514ee5109ba
https://pubmed.ncbi.nlm.nih.gov/23168827
https://pubmed.ncbi.nlm.nih.gov/23168827
Autor:
Ryan T, Demmer, Anthony, Squillaro, Panos N, Papapanou, Michael, Rosenbaum, William T, Friedewald, David R, Jacobs, Moïse, Desvarieux
Publikováno v:
Diabetes Care
OBJECTIVE Adverse microbial exposures might contribute to diabetogenesis. We hypothesized that clinical periodontal disease (a manifestation of microbial exposures in dysbiotic biofilms) would be related to insulin resistance among diabetes-free part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9393ed0e9d8b6880c190f7d2d1c4b423
https://pubmed.ncbi.nlm.nih.gov/22837370
https://pubmed.ncbi.nlm.nih.gov/22837370